The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples